| 2025 | | An Overview of Chronic Spontaneous Urticaria: Diagnosis, Management, and Treatment | 박해심 |
| 2025 | | Efficacy and Safety of Tezepelumab in Adults With Severe, Uncontrolled Asthma in Asia: Results From the Phase 3 DIRECTION Study | 박해심 |
| 2025 | | Pathogenesis of Chronic Spontaneous Urticaria With or Without Angioedema | 박해심 |
| 2025 | | Drug hypersensitivity reactions in children in clinical practice: A WAO Statement | 박해심 |
| 2025 | | A plain language summary of the MIRACLE study: benralizumab in people in Asia with severe asthma | 박해심 |
| 2025 | | Real-World Effectiveness of Omalizumab Treatment in Adult Asthma Patients | 박래웅, 박해심, 이영수, 장재혁 |
| 2025 | | Updating the classification and routine diagnosis of NSAID hypersensitivity reactions: A WAO Statement | 박해심 |
| 2025 | | Sputum immunoglobulin E levels correlate with eosinophilic airway regardless of atopy | 박해심 |
| 2025 | | Distinct Roles Between Eotaxin 1 and Eotaxin 2 in Asthmatic Airways | 박해심, 신유섭 |
| 2025 | | Real-World Effectiveness and Safety of Mepolizumab in Severe Eosinophilic Asthma: Insights From the Korean Severe Asthma Registry (KoSAR) | 박해심, 이영수 |
| 2025 | | Therapeutic Efficacy of YH35324 on FcεRIα-Mediated Mast Cell/Basophil Activation | 박해심, 예영민, 장재혁 |
| 2025 | | Therapeutic Potential of Arginine-Loaded Red Blood Cell Nanovesicles Targeting Obese Asthma | 박해심 |
| 2025 | | Relationships Between Chronic Cough and Asthma Control and Quality of Life in Patients With Severe Asthma: A 6-Month Longitudinal Analysis | 박해심, 이영수 |
| 2025 | | Adverse Impacts of Corticosteroid Treatment on Osteoporosis/Osteopenia in Adult Asthmatics: A Retrospective ICARUS Cohort Study | 박래웅, 박해심, 이영수, 장재혁 |
| 2024 | | Distinct Clinical Profiles of IgE and IgG Autoantibodies to Thyroid Peroxidase in Chronic Spontaneous Urticaria | 박해심, 예영민, 장재혁, 최보윤 |
| 2024 | | Gut permeability and its correlation with patient's traits and blood inflammatory markers in severe asthma: Real-world assessment from the Korean severe asthma registry-2 (KoSAR-2) | 박해심 |
| 2024 | | Update on Inflammatory Biomarkers for Defining Asthma Phenotype | 박해심 |
| 2024 | | Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024) | 박해심 |
| 2024 | | Serum Galectin-10: A biomarker for persistent airflow limitation in adult asthmatics | 박해심, 유민숙, 장재혁 |
| 2024 | | Association Between Cytokeratin 19-Specific IgG and Neutrophil Activation in Asthma | 박해심 |
| 2024 | | Downregulation of otulin induces inflammasome activation in neutrophilic asthma | 박용환, 박해심 |
| 2024 | | Association between specific IgE to staphylococcal enterotoxin B and the eosinophilic phenotype of asthma | 박해심 |
| 2024 | | Association of Cough Severity with Asthma Control and Quality of Life in Patients with Severe Asthma | 박해심, 이영수 |
| 2024 | | Real-World Effectiveness of Biologics in Patients With Severe Asthma: Analysis of the KoSAR | 박해심 |
| 2024 | | 8-Iso-prostaglandin F2α as a biomarker of type 2 low airway inflammation and remodeling in adult asthma | 박해심 |
| 2024 | | Benralizumab efficacy and safety in severe asthma: A randomized trial in Asia | 박해심 |
| 2024 | | Contribution of non-neuronal cholinergic system to T2-low airway inflammation in severe asthma | 박해심, 장재혁 |
| 2024 | | Work-related asthma in adults with severe asthma from the Korean Severe Asthma Registry (KoSAR) | 박해심, 이영수 |
| 2024 | | HLA-DRB1 is associated with cefaclor-induced immediate hypersensitivity | 박해심 |
| 2024 | | The effect of Bruton's tyrosine kinase (BTK) inhibitor in the eosinophilic asthma model of mouse | 박해심, 신유섭 |
| 2024 | | Predicting responses to omalizumab in antihistamine-refractory chronic urticaria: A real-world longitudinal study | 남동호, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2024 | | Cannabinoid receptor 2 as a regulator of inflammation induced oleoylethanolamide in eosinophilic asthma | 박해심, 신유섭, 예영민 |
| 2024 | | Lactobacillus paracasei-derived extracellular vesicles alleviate neutrophilic asthma by inhibiting the JNK pathway in airway epithelium | 박해심 |
| 2024 | | Immune Cell-Mediated Autoimmune Responses in Severe Asthma | 박해심, 장재혁 |
| 2024 | | Real-world treatment trajectories of adults with newly diagnosed asthma or COPD | 박래웅, 박해심, 이영수 |
| 2024 | | New targets for type 2-low asthma | 박해심 |
| 2024 | | Safety, Tolerability, Pharmacokinetics, and pharmacodynamics of YH35324, a novel Long-Acting High-Affinity IgETrap-Fc protein in subjects with Atopy: Results from the First-in-Human study | 박해심, 예영민 |
| 2024 | | Diagnostic biomarkers for chronic rhinosinusitis in adult asthmatics in real-world practice | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2024 | | ST2-Mediated Neutrophilic Airway Inflammation: A Therapeutic Target for Patients With Uncontrolled Asthma | 박해심, 신유섭, 장재혁, 최영우 |
| 2024 | | Real-World Effectiveness of Statin Therapy in Adult Asthma | 박래웅, 박해심, 양형모, 이영수, 장재혁 |
| 2024 | | Contribution of monocyte and macrophage extracellular traps to neutrophilic airway inflammation in severe asthma | 박해심, 신유섭, 유민숙, 장재혁, 최영우 |
| 2023 | | Prediction of the number of asthma patients using environmental factors based on deep learning algorithms | 박해심, 장재혁 |
| 2023 | | Corrigendum to “Engineering bispecific T-cell engagers to deplete eosinophils for the treatment of severe eosinophilic asthma” [Clinical Immunology 255 (2023) 109755] | 박해심 |
| 2023 | | Current Issues in the Management of IgG Subclass Deficiencies in Adults With Chronic Respiratory Diseases | 박해심, 장재혁 |
| 2023 | | Anti-heat shock protein 10 IgG in chronic spontaneous urticaria: Relation with miRNA-101-5p and platelet-activating factor | 강호철, 박해심, 신민경, 예영민, 조중현, 최보윤 |
| 2023 | | Nasal Transcriptome and Epigenome Analysis Identifies the Pathogenic Features of Aspirin-Exacerbated Respiratory Disease | 박해심, 예영민 |
| 2023 | | Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper | 박해심 |
| 2023 | | Engineering bispecific T-cell engagers to deplete eosinophils for the treatment of severe eosinophilic asthma | 박해심 |
| 2023 | | Long-term clinical outcomes of aspirin-exacerbated respiratory disease: Real-world data from an adult asthma cohort | 박래웅, 박해심, 이영수 |
| 2023 | | Long-term efficacy of anti-IL-4 receptor antibody in a patient with aspirin-exacerbated respiratory disease and IgG4-related disease | 박해심, 이영수, 장재혁, 전현섭 |
